| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 175 |
| 1 | INTERFERON BETA-1A | 127 |
| 2 | METHOTREXATE SODIUM | 105 |
| 3 | METHOTREXATE | 102 |
| 4 | OMEPRAZOLE MAGNESIUM | 102 |
| 5 | PREDNISONE | 96 |
| 6 | CLOZAPINE | 89 |
| 7 | ERGOCALCIFEROL | 82 |
| 8 | NATALIZUMAB | 82 |
| 9 | ASPIRIN | 80 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 3 | 0.0146 |
| 1 | COLESEVELAM HCL | 1 | 0.0135 |
| 2 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 2 | 0.0109 |
| 3 | BEVACIZUMAB-BVZR | 6 | 0.0085 |
| 4 | GLYCOPYRRONIUM | 9 | 0.0058 |
| 5 | METHYLENE BLUE | 9 | 0.0057 |
| 6 | CARBINOXAMINE MALEATE | 1 | 0.0052 |
| 7 | ETOMIDATE INJECTION | 11 | 0.0051 |
| 8 | TRIMIPRAMINE MALEATE | 2 | 0.0051 |
| 9 | CISATRACURIUM BESYLATE | 11 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 224 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 212 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 180 |
| 3 | Interferon beta [EPC] | 133 |
| 4 | Integrin Receptor Antagonist [EPC] | 130 |
| 5 | Benzodiazepine [EPC] | 129 |
| 6 | Atypical Antipsychotic [EPC] | 121 |
| 7 | Proton Pump Inhibitor [EPC] | 105 |
| 8 | Vitamin C [EPC] | 103 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 102 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Provitamin D2 Compound [EPC] | 82 | 0.0028 |
| 2 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 4 | Monobactam Antibacterial [EPC] | 5 | 0.0018 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 6 | Integrin Receptor Antagonist [EPC] | 130 | 0.0015 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 8 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |